Board member in Xspray Pharma acquires shares from the CEO
Anders Bladh, board member of Xspray Pharma, through his company Ribbskottet AB, has acquired 30,000 shares in Xspray Pharma from the CEO Per Andersson.
Xspray Pharma's CEO Per Andersson has sold 30,000 shares in Xspray Pharma, on March 13, 2023, to Board Member of Xspray Pharma, Anders Bladh via his company Ribbskottet AB. The transaction was completed outside stock market trading at a share price of SEK 72.00.
Ribbskottet increases its ownership to 2,480,000 shares. The traded shares constitute a minor part of Per Andersson’s holdings, totalling 212,294 after the transaction. The sale is due to private financial reasons.
“My holding in Xspray remains my single largest private financial investment by far. My commitment and strong belief in Xspray's future remains and I look forward to continuing leading and developing Xspray towards market launch and commercialization,” says Per Andersson, CEO of Xspray Pharma.